US2003133933A1PendingUtilityA1

Novel integrin alpha subunit

60
Priority: Feb 18, 1994Filed: Jun 21, 2002Published: Jul 17, 2003
Est. expiryFeb 18, 2014(expired)· nominal 20-yr term from priority
Inventors:Michael B. BrennerChristina M. Parker
C07K 14/70546A01K 2217/075A01K 2267/03C12N 15/8509A01K 2227/105A61K 38/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a novel integrin α E subunit and its functional equivalents. The invention further includes pharmaceutical compositions containing the isolated peptides, oligonucleotides encoding the peptides, vectors containing the oligonucleotides, and cell lines transfected with the vectors.

Claims

exact text as granted — not AI-modified
1 . A method for treating psoriasis, the method comprising administering to a subject in need of such treatment a therapeutically effective amount of an antibody that selectively binds to an αEβ7 integrin.  
     
     
         2 . A method for treating psoriasis, the method comprising administering to a subject in need of such treatment a therapeutically effective amount of an antibody that selectively binds to an integrin αE subunit.

Join the waitlist — get patent alerts

Track US2003133933A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.